1
|
Zheng XQ, Song LX, Han ZZ, Yang YB, Zhang Y, Gu LH, Yang L, Chou GX, Wang ZT. Pentacyclic triterpenoids from spikes of Prunella vulgaris L. with thyroid tumour cell cytostatic bioactivities. Nat Prod Res 2022; 37:1518-1526. [PMID: 35038938 DOI: 10.1080/14786419.2021.2024532] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Five new triterpenoids, including four ursane types (1-4) and one oleanane type (5), together with 15 known ursane types pentacyclic triterpenoids (6-20) were isolated from the fruit spikes of Prunella vulgaris L., a traditional Chinese herbal medicine. Their structures were elucidated based on IR, HR-ESI-MS, and NMR spectroscopic data. The SW579 cell line was used to evaluate anti-thyroid cancer activities of (1-20). The results indicated that (7-9), (16), and (19) exhibited apparent inhibitory activity with IC50 values of 25.73-71.41 μM (cisplatin as positive control, IC50 14.49 ± 0.97 μM). Network pharmacology and molecular docking were also used for the prediction of the synergistic actions and the underlying mechanisms. Accordingly, four potential targets have been characterized.
Collapse
Affiliation(s)
- Xiu-Qin Zheng
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Lei-Xin Song
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Zhu-Zhen Han
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.,Shanghai R&D Center for Standardization of Chinese Medicine, Shanghai, China
| | - Ying-Bo Yang
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Yi Zhang
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Li-Hua Gu
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.,Shanghai R&D Center for Standardization of Chinese Medicine, Shanghai, China
| | - Li Yang
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.,Shanghai R&D Center for Standardization of Chinese Medicine, Shanghai, China
| | - Gui-Xin Chou
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.,Shanghai R&D Center for Standardization of Chinese Medicine, Shanghai, China
| | - Zheng-Tao Wang
- Key Laboratory of Standardization of Chinese Medicines, Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.,Shanghai R&D Center for Standardization of Chinese Medicine, Shanghai, China
| |
Collapse
|
2
|
Liu Z, Liu G, Liu X, Li S. The effects of hyperoside on apoptosis and the expression of Fas/FasL and survivin in SW579 human thyroid squamous cell carcinoma cell line. Oncol Lett 2017; 14:2310-2314. [PMID: 28789450 PMCID: PMC5530074 DOI: 10.3892/ol.2017.6453] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2017] [Accepted: 05/29/2017] [Indexed: 01/22/2023] Open
Abstract
This study investigated the effects of hyperoside on apoptosis of human thyroid squamous cell carcinoma cells (SW579) and measured changes in the expression of known apoptosis regulatory players Fas/FasL and survivin. SW579 cells were treated with increasing concentrations of hyperoside. The cell proliferation inhibition rate was measured by MTT assay. Morphological changes in cells were observed by microscopy. Cell apoptosis was detected by flow cytometry using AV-PI double staining. The normalized expression levels of Fas and FasL mRNAs were detected by reverse transcription quantitative PCR (RT-qPCR), and the expression of the survivin protein was detected by western blotting. Our results showed that hyperoside significantly inhibited the activity of SW579 cells; obvious morphological changes were observed and apoptosis was induced in a dose-dependent manner. Hyperoside was shown to upregulate the expression of Fas and FasL mRNAs and downregulate the expression of the survivin protein. The results suggested that hyperoside can induce the apoptosis of the SW579 human thyroid squamous cell carcinoma cell line, and partially by upregulating the expression of Fas and FasL mRNAs and downregulating the expression of survivin protein in the process of apoptosis. Further studies on the use of hyperoside against cancer cells are required.
Collapse
Affiliation(s)
- Zhenfang Liu
- Department of General Surgery, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China
| | - Guodong Liu
- Department of General Surgery, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China
| | - Xiaowei Liu
- Department of General Surgery, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China
| | - Shouchao Li
- Department of General Surgery, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
| |
Collapse
|